Atavistik Bio Funding & Investors
Cambridge, MA
Atavistik Bio is a pre-clinical biotechnology company pioneering the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-in-class drug candidates powered by distinct allosteric control mechanisms.
atavistikbio.comTotal Amount Raised: $100,000,000
Atavistik Bio Funding Rounds
Series Unknown
$40,000,000
Series Unknown Investors
Column GroupNextech InvestLux CapitalSeries A
$60,000,000
Series A Investors
Column GroupNextech InvestLux Capital
Funding info provided by Diffbot.